Hannah R. Eckert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hannah R. Eckert has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Cooper R. Roslund
Department of Biological Sciences, University of Idaho, Moscow, Idaho, USA
1 shared publicationDina A. Boikov
Department of Internal Medicine, Division Infectious Diseases, Wayne State University School of Medicine, Detroit, Michigan, USA
1 shared publication- Emily A. Kizer
Department of Biological Sciences, University of Idaho, Moscow, Idaho, USA
1 shared publication Jack D. Sobel
Department of Internal Medicine, Division Infectious Diseases, Wayne State University School of Medicine, Detroit, Michigan, USA
1 shared publication- Lance R. Fredericks
University of Idaho
1 shared publication - Mark D. Lee
Department of Biochemistry, University of Utah, Salt Lake City, Utah 84112
1 shared publication
Latest Publications
- Open Access
- 17 June 2021
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (7)
Vaginal Isolates of Candida glabrata Are Uniquely Susceptible to Ionophoric Killer Toxins Produced by Saccharomyces cerevisiae
Compared to other species of Candida yeasts, the growth of Candida glabrata was inhibited by many different strains of Saccharomyces killer yeasts. The ionophoric K1 and K2 killer toxins were broadly inhibitory to all clinical isolates of C. glabrata from patients with recurrent vulvovaginal candidiasis despite high levels of resistance to clinically relevant antifungal therapeutics.
- 17 June 2021
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (7)
Open AccessVaginal Isolates of Candida glabrata Are Uniquely Susceptible to Ionophoric Killer Toxins Produced by Saccharomyces cerevisiae
Compared to other species of Candida yeasts, the growth of Candida glabrata was inhibited by many different strains of Saccharomyces killer yeasts. The ionophoric K1 and K2 killer toxins were broadly inhibitory to all clinical isolates of C. glabrata from patients with recurrent vulvovaginal candidiasis despite high levels of resistance to clinically relevant antifungal therapeutics.